Tempus AI PE Ratio 1970-1969 | TEM
Current and historical p/e ratio for Tempus AI (TEM) from 1970 to 1969. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Tempus AI PE ratio as of June 28, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Tempus AI PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2024-06-28 | 35.00 | inf | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $5.769B | $0.000B |
| Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $35.568B | 19.53 |
| Hims & Hers Health (HIMS) | United States | $4.337B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.976B | 0.00 |
| Axonics (AXNX) | United States | $3.430B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.348B | 0.00 |
| Olink Holding AB (publ) (OLK) | Sweden | $3.168B | 0.00 |
| Azenta (AZTA) | United States | $2.836B | 159.46 |
| Enovis (ENOV) | United States | $2.479B | 18.37 |
| 10x Genomics (TXG) | United States | $2.318B | 0.00 |
| Privia Health (PRVA) | United States | $2.074B | 115.87 |
| Schrodinger (SDGR) | United States | $1.406B | 0.00 |
| Omnicell (OMCL) | United States | $1.243B | 42.97 |
| Phreesia (PHR) | United States | $1.217B | 0.00 |
| Standard BioTools (LAB) | United States | $0.656B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.644B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.611B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.587B | 0.00 |
| Talkspace (TALK) | United States | $0.390B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.377B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.299B | 0.00 |
| Pulmonx (LUNG) | United States | $0.246B | 0.00 |
| Outset Medical (OM) | United States | $0.199B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.177B | 0.00 |
| TruBridge (TBRG) | United States | $0.150B | 8.06 |
| P3 Health Partners (PIII) | United States | $0.142B | 0.00 |
| American Well (AMWL) | United States | $0.096B | 0.00 |
| 111 (YI) | China | $0.091B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.076B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.075B | 0.00 |
| HeartBeam (BEAT) | United States | $0.068B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.064B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.045B | 0.00 |
| Augmedix (AUGX) | United States | $0.043B | 0.00 |
| Zepp Health (ZEPP) | China | $0.036B | 0.00 |
| Akili (AKLI) | United States | $0.034B | 0.00 |
| CareCloud (CCLD) | United States | $0.031B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.029B | 0.00 |
| Movano (MOVE) | United States | $0.027B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.027B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Syra Health (SYRA) | United States | $0.009B | 0.00 |
| Biotricity (BTCY) | United States | $0.008B | 0.00 |
| Transgenomic (PRPO) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.003B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |